Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Rejnmark, L., Gosmanova, E. O., Khan, A. A., Makita, N., Imanishi, Y., Takeuchi, Y., Sprague, S., Shoback, D. M., Kohlmeier, L., Rubin, M. R., Palermo, A., Schwarz, P., Gagnon, C., Tsourdi, E., Zhao, C., Makara, M. A., Ominsky, M. S., Lai, B., Ukena, J. ... Shu, A. D. (2024). Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial. Advances in Therapy, 41(6), 2500-2518. https://doi.org/10.1007/s12325-024-02843-8
Bladbjerg, E. M., Levy-Schousboe, K., Frimodt-Møller, M., Kjærgaard, K. D., Strandhave, C., Brasen, C. L., Frandsen, N. E., Hansen, D. & Marckmann, P. (2024). No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled Study. Journal of Renal Nutrition, 34(4), 337-342. https://doi.org/10.1053/j.jrn.2023.11.007
Svart, K., Korsbæk, J. J., Jensen, R. H., Parkner, T., Knudsen, C. S., Hasselbalch, S. G., Hagen, S. M., Wibroe, E. A., Molander, L. D. & Beier, D. (2024). Neurofilament light chain is elevated in patients with newly diagnosed idiopathic intracranial hypertension: A prospective study. Cephalalgia, 44(5), 3331024241248203. https://doi.org/10.1177/03331024241248203
Boulakh, L., Isaksen, J. L., Poulsen, H. E., Faber, J., Heegaard, S., Nygaard, B., Kanters, J. K., Toft, P. B., Mortens Udholm, P., Bek, T., Buch Hesgaard, H. & Ellervik, C. (2024). Thyroid dysfunction and exudative age-related macular degeneration – A longitudinal nationwide registry-based cohort study. Acta Ophthalmologica, 102(7), 813-820. https://doi.org/10.1111/aos.16705
Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M.-L., Jerome, K. R., Sampoleo, R., Mills, M. G., Greninger, A. L., Juneja, K., Porter, D., Benson, C. A., Dempsey, W., El Sahly, H. M. ... Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members (2024). SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir. The Journal of Infectious Diseases, 230(3), 624-634. https://doi.org/10.1093/infdis/jiae198